Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 2Sarcoidosis 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pancreatic Cyst 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Lymphoma 1Lymphadenopathy 1Lung Neoplasms 1Disease 1

Interventions

Cyclophosphamide 37Etoposide 25Vincristine 24Cytarabine 21Doxorubicin 19Rituximab 17Radiotherapy 17Peripheral Blood Stem Cell Transplantation 16Melphalan 16Prednisolone 14Methotrexate 14Filgrastim 13fludarabine phosphate 11Prednisone 11Dexamethasone 11Carmustine 9Bleomycin 9pegylated granulocyte colony-stimulating factor 8Cyclosporine 8Busulfan 8fludarabine 7Ifosfamide 7Cisplatin 7sargramostim 6Vinblastine 6Mitoxantrone 6Methylprednisolone 6Gemcitabine 6Chlorambucil 6Antilymphocyte Serum 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphoma × Needles × Clear all
NCT03573362 2023-02-17

Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma

Centre hospitalier de l'Université de Montréal (CHUM)

Phase NA Unknown
50 enrolled
Lymphoid

Lymphoma, Sarcoidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡